Departments treating patients with implantable intrathecal drug pumps have received the following warning from the Medicines and Healthcare products Regulatory Agency (MHRA):
Device: Implantable drug pumps for intrathecal therapy. All manufacturers.
Problem: Risk of temporary or permanent neurological impairment due to inflammatory or granulomatous mass formation at the catheter tip.
MRI services should be aware that requests may come through for imaging and care will need to be exercised regarding catheter and any attachments.
Download the full alert.
